← Russell 3000 cross-section

WRBY Warby Parker Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-06, not restated
Healthcare

Scale

Market cap
$3.2bn
Revenue TTM
$912m
Net income TTM
$8m
Free cash flow
$22m
Composite score
41.9
Sector rank
#1356

Valuation

P / E
415.1
EV / EBITDA
53.1
EV / sales
3.2
FCF yield
0.68%
Earnings yield vs 10-yr
-4.49pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
0.8%
EBITDA margin
6.0%
ROE
2.0%
ROIC
1.6%
Revenue growth
11.0%

Insider activity, last 90 days

Net open-market
$-17.69m
Buyers
0
Sellers
5

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Financial Highlights For the three months ended June 30, 2026 and 2025: • we generated net revenue of $235.5 million and $214.5 million, respectively; • we generated gross profit of $136.5 million and $113.6 million, respectively, representing a gross margin of 57.9% and 53.0%, respectively; • we generated net income of $4.6 million and net loss of $1.8 million, respectively; and • we generated Adjusted EBITDA of $32.9 million and $25.0 million, respectively, representing an Adjusted EBITDA Margin of 14.0% and 11.7%, respectively. …Warby Parker Inc., 10-Q, period ended 2026-06-30, filed 2026-08-06

Read the full passage →